SCHEMBL147806

SCHEMBL147806

[CH2]CCCCCCCCCC(=O)O

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 5/20 0.71
LMNA P02545 3/20 0.71
NFKB1 P19838 1/20 0.71
PMP22 Q01453 1/20 0.71
GPR84 Q9NQS5 8/20 0.57
FFAR1 O14842 2/20 0.57
FFAR4 Q5NUL3 2/20 0.57
SLC22A6 Q4U2R8 2/20 0.56
PPARG P37231 7/20 0.55
PPARD Q03181 7/20 0.55
PPARA Q07869 7/20 0.55
HDAC11 Q96DB2 5/20 0.55
ALDH1A1 P00352 3/20 0.55
PTPN1 P18031 3/20 0.55
TLR2 O60603 2/20 0.55
TDP1 Q9NUW8 2/20 0.55
MEN1 O00255 2/20 0.55
FABP4 P15090 2/20 0.55
ALOX15 P16050 2/20 0.55
KMT2A Q03164 2/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL248269 1.00 TSHR (0.71) TSHRLMNANFKB1PMP22GPR84
SCHEMBL249583 1.00 TSHR (0.71) TSHRLMNANFKB1PMP22GPR84
SCHEMBL251208 1.00 TSHR (0.71) TSHRLMNANFKB1PMP22GPR84
SCHEMBL3406713 1.00 TSHR (0.71) TSHRLMNANFKB1PMP22GPR84
SCHEMBL342408 1.00 TSHR (0.71) TSHRLMNANFKB1PMP22GPR84
SCHEMBL251332 1.00 TSHR (0.71) TSHRLMNANFKB1PMP22GPR84
SCHEMBL227302 1.00 TSHR (0.71) TSHRLMNANFKB1PMP22GPR84
SCHEMBL200185 1.00 TSHR (0.71) TSHRLMNANFKB1PMP22GPR84
SCHEMBL250323 1.00 TSHR (0.71) TSHRLMNANFKB1PMP22GPR84
SCHEMBL251008 1.00 TSHR (0.71) TSHRLMNANFKB1PMP22GPR84

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 862 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116344146-A Silicon oil-based magnetic fluid and preparation method thereof 上海交通大学 2023-06-27 CN claimed
CN-110357749-B Emulsifier for emulsion explosive, preparation method thereof, emulsion matrix and emulsion explosive 北矿亿博(沧州)科技有限责任公司 2021-02-26 CN claimed
US-8344142-B2 perylenetetracarboxylic diimide core having side chains (groups or mesogens) attached to the core; to provide charge-transport materials having various volatilities, solubilities, crystallinity, and charge transport ability; organic light emitting diode; photovoltaic cells, light-emitting diodes GEORGIA TECH RESEARCH CORPORATION (US) 2013-01-01 US claimed
US-8039625-B2 Coronene charge-transport materials, methods of fabrication thereof, and methods of use thereof GEORGIA TECH RESEARCH CORPORATION (US) 2011-10-18 US claimed
US-20090044863-A1 CORONENE CHARGE-TRANSPORT MATERIALS, METHODS OF FABRICATION THEREOF, AND METHODS OF USE THEREOF NATIONAL SCIENCE FOUNDATION 2009-02-19 US claimed
US-20080223444-A1 Perylene Charge-Transport Materials, Methods of Fabrication Thereof, and Methods of Use Thereof GEORGIA TECH RESEARCH CORPORATION 2008-09-18 US claimed
WO-2006093965-A2 CORONENE CHARGE-TRANSPORT MATERIALS, METHODS OF FABRICATION THEREOF, AND METHODS OF USE THEREOF GEORGIA TECH RESEARCH CORPORATION (US) 2006-09-08 WO claimed
US-7074387-B2 DTPA monoamides, pharmaceutical agents containing these compounds, their use and process for their production SCHERING AG (DE) 2006-07-11 US claimed
WO-2005124453-A2 PERYLENE CHARGE-TRANSPORT MATERIALS, METHODS OF FABRICATION THEREOF, AND METHODS OF USE THEREOF GEORGIA TECH RESEARCH CORPORATION (US) 2005-12-29 WO claimed
US-20030202943-A1 DTPA monoamides, pharmaceutical agents containing these compounds, their use and process for their production SCHERING AKTIENGESELLSCHAFT (DE) 2003-10-30 US claimed
US-6287538-B1 CONTRAST AGENT SCHERING AKTIENGESELLSCHAFT (DE) 2001-09-11 US claimed
US-5859214-A DTPA monoamides, pharmaceutical agents containing these compounds, their use and process for their production SCHERING AKTIENGESELLSHAFT (DE) 1999-01-12 US claimed
US-5843399-A DTPA monoamides for MRI SCHERING AKTIENGESELLSCHAFT (DE) 1998-12-01 US claimed
EP-0569189-B1 Organopolysiloxanes and methods for making SHINETSU CHEMICAL CO (JP) 1996-09-18 EP claimed
US-5332796-A Organopolysiloxanes and methods for making SHIN-ETSU CHEMICAL CO., LTD. (JP) 1994-07-26 US claimed
EP-0450742-B1 DTPA-Monoamids, pharmaceutical compositions containing them, their use and process for their preparation SCHERING AG (DE) 1994-07-06 EP claimed
EP-0569189-A1 Organopolysiloxanes and methods for making Shin-Etsu Chemical Co., Ltd. (JP) 1993-11-10 EP claimed
EP-0450742-A1 DTPA-Monoamids, pharmaceutical compositions containing them, their use and process for their preparation SCHERING AKTIENGESELLSCHAFT (DE) 1991-10-09 EP claimed
US-4844841-A Pyrenexulfonic acids useful in fluorescent lipid probes KOLLER ERNST (AT) 1989-07-04 US claimed
EP-0000930-B1 N-CARBOXYALKANE-AMINOALKANE-DIPHOSPHONIC ACIDS, N-CARBOXYALKANE-AZACYCLOALKANE-DIPHOSPHONIC ACIDS AND N-CARBOXYALKANE-AMINOARYLKANE DIPHOSPHONIC ACIDS, PROCESS FOR THEIR PREPARATION AND THEIR USE AS SEQUESTERING AGENTS Benckiser-Knapsack GmbH (DE) 1981-07-01 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030202943-A1 DTPA monoamides, pharmaceutical agents containing these compounds, their use and process for their production SLC43A1, HRH4, ACSL6 TSHR 932/4885LMNA 1863/4885NFKB1 2214/4885
US-20080223444-A1 Perylene Charge-Transport Materials, Methods of Fabrication Thereof, and Methods of Use Thereof SLC43A1, SLC3A2, SLC16A3 TSHR 4842/4885LMNA 193/4885NFKB1 4767/4885
US-20090044863-A1 CORONENE CHARGE-TRANSPORT MATERIALS, METHODS OF FABRICATION THEREOF, AND METHODS OF USE THEREOF SLC18A3, CORO1C, SLC18A1 TSHR 4833/4885LMNA 424/4885NFKB1 4626/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.